Investing in dividend stocks is a great way to earn superior returns over the long run.
How do we know that?
According to some research, most of the S&P 500’s returns over the past several decades can be attributed to reinvested dividends and compounding. This fact makes a strong case for dividend investing. However, buying shares in just any old company that happens to pay dividends isn’t the way to go: They aren’t all created equal.
With that said, let’s consider three excellent dividend stocks that are worth investors’ hard-earned cash: Bristol Myers Squibb (NYSE: BMY), Merck (NYSE: MRK), and Medtronic (NYSE: MDT). Here’s why these three income stocks are worth sticking with for the long term. 1. Bristol Myers Squibb Bristol Myers is a leading pharmaceutical company with a deep portfolio of medicines spanning many therapeutic areas, particularly oncology.